Cargando…

Missing data on accessibility of children’s medicines

Child-appropriate medicines are essential for the safe and effective treatment of children, yet we have observed a large gap in the data required to adequately monitor access to these medicines. We have examined data on the availability and pricing of child-appropriate medicines across 50 surveys. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joosse, Iris R, Mantel-Teeuwisse, Aukje K, Wirtz, Veronika J, Suleman, Fatima, van den Ham, Hendrika A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2022
Materias:	Policy & Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511669/ https://www.ncbi.nlm.nih.gov/pubmed/36188021 http://dx.doi.org/10.2471/BLT.22.288137

Ejemplares similares

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

SDG indicator 3.b.3 – an analysis of its robustness and challenges for measuring access to medicines for children
por: Joosse, I. R., et al.
Publicado: (2023)

European collaborations on medicine and vaccine procurement
por: Vogler, Sabine, et al.
Publicado: (2021)

Evidence on the effectiveness of policies promoting price transparency - A systematic review
por: Joosse, Iris R., et al.
Publicado: (2023)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Healthcare workers’ perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2022)

Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2020)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Access to hepatitis C medicines
por: Edwards, Danny J, et al.
Publicado: (2015)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Access to insulin: applying the concept of security of supply to medicines
por: Beran, David, et al.
Publicado: (2019)

Reclassifying contraceptives as over-the-counter medicines to improve access
por: Ammerdorffer, Anne, et al.
Publicado: (2022)

Ethnicity and socioeconomic status: missing in research means missing in clinical guidance
por: Beard, Eleanor, et al.
Publicado: (2021)

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018
por: Kibira, Denis, et al.
Publicado: (2021)

Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review
por: Jacobs, Tom G., et al.
Publicado: (2019)

Donor Commitments and Disbursements for Sexual and Reproductive Health Aid in Kenya, Tanzania, Uganda and Zambia
por: Kibira, Denis, et al.
Publicado: (2021)

A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya
por: Perehudoff, Katrina, et al.
Publicado: (2022)

Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts
por: Hogervorst, Milou A, et al.
Publicado: (2023)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya
por: Ooms, Gaby Isabelle, et al.
Publicado: (2021)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

COVID-19: Hands, face, space, fresh air ... and exercise! The missing intervention to reduce disease burden
por: Tumi, Aessa, et al.
Publicado: (2021)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
por: Kusynová, Zuzana, et al.
Publicado: (2023)

The Application and Implications of Novel Deterministic Sensitivity Analysis Methods
por: Vreman, Rick A., et al.
Publicado: (2020)

The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance
por: Zanichelli, Veronica, et al.
Publicado: (2023)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

Access to adults’ hearing aids: policies and technologies used in eight countries
por: Yong, Michael, et al.
Publicado: (2019)

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2013)

National medicines policy development, Saudi Arabia
por: Almoteiry, Khalid, et al.
Publicado: (2022)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Strengthening family medicine: a Canadian perspective and the RCGP International and Overseas Network
por: Agarwal, Gina
Publicado: (2017)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Family medicine and physician reimbursement: a US perspective and the RCGP International and Overseas Network
por: Uko, Ayotunde Monica
Publicado: (2018)

Family medicine as an emerging specialty: a Pakistani perspective and the RCGP International Overseas Network
por: Amin, Faridah, et al.
Publicado: (2018)

Research evidence is essential for the development of family medicine as a discipline in the Japanese healthcare system
por: Kaneko, Makoto, et al.
Publicado: (2019)

Hyperglycaemia-induced diabetic amyotrophy: a case report from a family medicine clinic
por: Wattanapisit, Apichai, et al.
Publicado: (2020)

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
por: ‘t Hoen, Ellen FM, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d7ptonkr9g1h9k8uecujtoe444